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Introduction 
 
 Type 1 diabetes (T1D) is an autoimmune disease that occurs when T lymphocyte 
cells attack and destroy beta cells in the pancreas.1  The cause of T1D is considered to be 
a combination of genetic predisposition and environmental or lifestyle risk factors.  
Destruction of the pancreatic islet beta cells, which secrete insulin, leads to complete 
dependency on exogenous insulin to maintain glucose homeostasis.  Insulin is a hormone 
that stimulates glucose uptake as well as lipid synthesis and is important for maintaining 
blood glucose levels.1  In most cases of T1D, people have inherited risk factors from both 
parents.  The most important genes implicated with susceptibility to T1D are the human 
leukocyte antigen (HLA) complex on chromosome 6.2  Most young children with T1D 
carry either or both susceptibility haplotypes in the HLA class II region (90-95%).2  In the 
United States, individuals with a first-degree relative with T1D have a 1 in 20 lifetime 
risk of developing T1D, compared to a 1 in 300 lifetime risk for the general population.3 
Caucasians have the highest rate of T1D, therefore, it is possible that these inherited risk 
factors are more common in Caucasians.4  Maahs et al. (2010) conclude that the rates of 
T1D in non-Hispanic white youth are among the highest in the world (prevalence of T1D 
was 2.0/1,000 and the incidence was 23.6/100,000).2  In 2002-2003, children with T1D 
(n=1905) were diagnosed in the SEARCH for Diabetes in Youth study (SEARCH) from 
a population of more than 10 million.2  Rates were highest in non-Hispanic white youth 
as compared to other races/ethnicities and were slightly higher in females as compared to 
males (RR 1.028; 95% CI 1.025-1.030).2  The EURODIAB ACE study group looked at 
the variation and trends in incidence of childhood diabetes in Europe between 1989 and 
1994.2  This study group found that the annual increase in the incidence rate of T1D was 
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3.4% (95% CI 2.5-4.4%).2  The rates of increase were found to be highest in the youngest 
age group: ages 0-4 years 6.3% (95% CI 1.5-8.5%), 5-9 years 3.1% (95% CI 1.5-4.8%), 
and 10-14 years 2.4% (95% CI 1.0-3.8%).2  However, since an environmental trigger is 
also involved in the development of the disease when an individual has already inherited 
a predisposition to diabetes, it may take years for T1D to develop in an individual with a 
predisposition.4  In studies following relatives of people with T1D, researchers found that 
those who developed T1D later in life had certain autoantibodies in their blood for years 
prior to the development of the disease.4  Four autoantibodies are markers of beta cell 
autoimmunity in type 1 diabetes: islet cell cytoplasmic autoantibodies (ICA), insulin 
autoantibodies (IAA), antibodies to the 65-kDa isoform of glutamic acid decarboxylase 
(GADA), and antibodies to the protein tyrosine phosphate-related IA-2 molecule (IA-
2A).5   Autoantibodies against GAD 65 are found in 80% of persons with type 1 diabetes.6  
Presence of ICA and IA-2A at diagnosis for type 1 diabetes range from about 69-90% 
and 54-75%.6  Insulin autoantibodies are usually the first marker in young children at risk 
for diabetes and found in approximately 70% of young children at time of diagnosis.6  
The more antibodies present in an individual, the greater the risk of developing type 1 
diabetes.6 
 Many people at risk for type 1 diabetes do not develop it.  Researchers have 
examined associations between various environmental triggers and development of the 
disease.  Cold climate, viruses, intestinal microbiota, infant diet, birth weight, and infant 
weight gain are environmental factors thought to play a role in the risk of developing 
T1D.4  One trigger may be related to cold weather; more cases of T1D develop in the 
winter and more cases are seen in areas with cold climates.7  According to Waernbaum 
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and Dahlquist (2016), there is an association with incidence of type 1 diabetes in children 
and low mean temperature independent of a possible effect of sunshine hours after 
adjustment for age, sex, and time trend.8  Some researchers suggest viruses that have mild 
effects on some individuals could trigger T1D in others.7   Enteroviral infection, in 
particular Coxsackie B4, showed an accelerated prediabetes progression in diabetes-
prone NOD mice.5  Early introduction of diet is thought to play a role in the development 
of T1D as it is less common in people who were breastfed and who were introduced to 
solid foods at later ages.  The protection that breastfeeding can offer against the 
development of childhood obesity and T1D in children at risk for T1D is unknown and 
may be related to many different factors.  The purpose of this project is to review the 
literature on the association between infant diet, including breastfeeding and 
complementary foods, and the development of obesity and T1D.  This information will 
be used to prepare a secondary analysis proposal to examine the association between 
length of exclusive breastfeeding and obesity risk in children at risk for T1D for 
submission to the Presentations and Publications Committee of the Trial to Reduce 
IDDM in the Genetically at Risk (TRIGR) study. 
 
Specific Aim 1: To describe the association between length of exclusive breastfeeding 
and obesity in children at risk for T1D 
Hypothesis 1: Shorter duration of exclusive breastfeeding predisposes children to 
obesity 
Null Hypothesis 1:  There will be no difference in obesity risk by length of 
exclusive breastfeeding  
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Specific Aim 2: To determine the association between length of exclusive breastfeeding 
and the development of obesity in children at risk for T1D is modified by maternal T1D 
status 
Hypothesis 2: Risk of obesity will be higher in children who have a mother with 
T1D 
Null Hypothesis 2:  There will be no difference in obesity risk by maternal T1D 
status 
 
Literature Review 
Nutrition and Type 1 Diabetes  
Breastfeeding and Infant Formula 
 Breastfeeding has several benefits for infants.  There are three phases in breast 
milk production: colostrum (day 1 to 5 postpartum), transitional milk (day 6 to 15 
postpartum), and mature milk (after day 15 postpartum).9  Colostrum contains substances 
that offer general benefits, such as growth factors involved in the growth and 
development of cells in the digestive tract and transfer factors that may have general 
immune-activating properties.10   In addition to immunoglobulins, colostrum contains 
neutrophils and macrophages, which secrete a range of immune-related components 
including cytokines and antimicrobial proteins and peptides, such as lysozyme, 
lactoferrin, and proline-rich polypeptides.10    Phospholipids in human milk are an 
important source of energy for infants and are also providers of long-chain 
polyunsaturated fatty acids, which play an important role in the growth and brain 
development of neonates.11   Fatty acids of high nutritional relevance such as arachidonic 
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acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) found in 
human milk are involved in child growth, visual acuity, and neurological development.11   
The World Health Organization (WHO) recommends exclusive breastfeeding up to six 
months of age.12  Previous research has suggested that breast feeding for shorter than 
three months and early exposure to cow’s milk proteins (such as bovine serum albumin) 
can trigger diabetes.13  Some retrospective studies have shown a small reduction in the 
risk for T1D with breastfeeding; however, all but one of the prospective birth cohort 
studies failed to find a protective effect.7  
 These findings suggest that breastfeeding may play a protective role in the 
relationship between dietary factors and T1D.7   Butalia et al. (2016) discusses a case-
control study by Borch-Johnsen (1984) demonstrating that children with T1D were 
breastfed for shorter durations than their healthy siblings and general population.14  Those 
who were exclusively breastfed for longer than 2 weeks were at decreased risk for 
developing T1D, but the protection was attenuated for those exclusively breastfed for 
more than 3 months.14  It is possible that products with cow’s milk-based protein may 
increase the risk for advanced beta-cell autoimmunity, whereas breastfeeding may be 
protective because breast milk has several antimicrobial and anti-inflammatory 
properties.14  One possible mechanism is that early introduction of cow’s milk protein 
may induce mucosal inflammation and increased gut permeability.14  This increases the 
permeability of food antigens through the intestine, which leads to the stimulation of 
autoimmune processes, pancreatic islet inflammation, and destruction of beta cells.14 
 While breastfeeding may play a protective role in the risk for developing T1D, it 
is also important to look at other diet influences.  In a double-blind, randomized trial 
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(TRIGR Pilot II) 230 infants genetically at risk for T1D were randomly assigned either 
the intervention formula (extensively hydrolyzed casein-based formula) or the control 
formula (80% intact milk protein and 20% hydrolyzed milk protein) whenever breast 
milk was not available.7   At least one autoantibody developed in 17 of the children in the 
casein hydrolysate group (17%) and 33 in the control group (30%).7  However, the larger 
phase three of the TRIGR study could not confirm this same effect on islet autoimmunity, 
and follow up of the study participants for T1D continues.7  A higher cow’s milk intake 
in children with islet autoimmunity might lead to T1D; however, the effect could be 
mediated by certain fatty acids present in cow’s milk.7  If this were confirmed, further 
dietary interventions to examine the preventive effect of diet on the development of On 
T1D could be conducted. 
 One recent paper published reported breastfeeding, other milk feeding, and 
complementary feeding patterns among infants in the TRIGR study.  The large 
population (n=2159) consisting of participants from 15 different countries provides an 
assessment of infant feeding patterns in different regions of the world in mothers with 
and without T1D.15  This paper documented that mothers with T1D breastfeed less than 
those unaffected by the disease.15  During the first 3 days of life, the proportion of 
exclusively breastfed infants of mothers with T1D ranged from 81% in Northern Europe 
to 32% in Australia, but 94% of Australian mothers without T1D exclusively breastfed 
their infants during the first 3 days of life.15   Sorkio et al. (2010) found that most (90%) 
of the infants of mothers with and without T1D were initially breastfed, but breastfeeding 
rates declined more among mothers with (50%) than without (72%) T1D at 6 months.16 
The feeding pattern data from the TRIGR study will allow for evaluation of how infant 
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diet is related to the development of autoimmunity and then progression to T1D by region 
at the completion of the study in 2017.15 
 
Complementary Foods  
 The American Academy of Pediatrics recommends waiting until 6 months of age 
to start introducing solid foods, and to continue breastfeeding in combination with 
complementary foods until 12 months of age if possible.17   Several studies have looked at 
the association between introduction of solid foods and risk for T1D.  Children initially 
exposed to cereals between ages 0 and 3 months and those who were exposed at 7 months 
of age or older had increased hazard of islet autoimmunity (4.32; 95% CI 2.0-9.35 and 
5.36; 95% CI 2.08-13.8; respectively) compared with those who were first exposed 
during the fourth through sixth month of life after adjustment for HLA genotype, family 
history of T1D, ethnicity, and maternal age.18   The Finnish Diabetes Prediction and 
Prevention (DIPP) study reported that early introduction (by 4 months of age) of root 
vegetables increased the risk (1.75; 95% CI 1.11-2.75) of islet autoimmunity compared 
with a later introduction of root vegetables.19  Researchers also reported that first 
exposure to egg before eight months of age was associated with an increased risk of islet 
autoimmunity.14  All Babies in Southeast Sweden (ABIS) showed that less than daily 
consumption of vegetables (3-5 times per week) in the mother’s diet was associated with 
increased risk (1.17; 95% CI 1.24-2.35) of islet autoimmunity.14  It is important to 
interpret these study results with caution because there is a risk of false positive 
associations caused by multiple comparisons.  There are some inconsistencies with the 
findings, but these studies support the idea that general antigenic stimulation is more 
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important than the actual antigen in this disease process.14  In other words, the timing of 
introduction of certain solid foods could be more important than the type of food 
introduced.  This could be due to immature immune response and the gut.  
 Introducing solid foods too soon may be a risk factor for developing islet 
autoimmunity due to immature immune response to foreign antigens and a more 
permeable gut in infants.20  Abnormalities in gut permeability have been linked to the 
development of T1D.20  In a multinational cohort study of children at increased genetic 
risk of T1D, a reduction in the risk of islet autoimmunity was observed in children that 
received probiotics via dietary supplements and/or via fortified infant formula before or 
at the age of 27 days compared with those who first received probiotics after 27 days or 
not at all.20  Early probiotic exposure was associated with a 60% decrease in the risk of 
islet autoimmunity among children with the DR3/4 genotype but not among other 
genotypes.20  While studies have shown that breastfeeding for at least six months may 
help reduce the risk of T1D, breastfeeding is not possible for some mothers for a variety 
of factors.20  If mothers must use a formula, it appears that selecting a formula fortified 
with probiotics may be beneficial in helping reduce the risk of T1D in children 
genetically at risk.20  More research should be conducted to determine the effect of 
supplemental probiotics on the development of autoimmunity and T1D in breastfed 
infants who are genetically at risk. 
 
Micronutrients  
 Previous research has provided some evidence to support a potential role of 
vitamin D in the pathogenesis of T1D, and the factor believed to play a role is vitamin D 
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receptor (VDR).14  The VDR gene is found in most tissues of the body, including the 
immune system.14  The VDR gene is located on chromosome 12 and has a few allelic 
variants.  Some of these variations of the gene have been associated with an increased 
risk for T1D.14  Countries at northern latitudes where sunlight exposure is lower and 
vitamin D deficiency is more common have a higher incidence of T1D.14  Several studies 
have reported lower levels of serum 25-OH vitamin D among patients with T1D 
compared with healthy controls.14 The Endocrine Society Practice Guidelines on Vitamin 
D define vitamin D deficiency as 25(OH)D <20 nanograms/mL, insufficiency as 21-29 
nanograms/mL, and sufficiency as >30 nanograms/mL.21  On the contrary, a cohort study 
of maternal intake of vitamin D was not found to be protective in offspring developing 
T1D and beta-cell antibodies.14  Virtanen and Knip (2003) reviewed the results of a few 
studies that evaluated vitamin D supplementation in infancy.22   Vitamin D 
supplementation during infancy was inversely associated with the risk of T1D in a 
European case-control comparison, whereas vitamin D or cod liver oil use during infancy 
was not related to the risk of diabetes in a small Norwegian case-control series.22  Due to 
contrary findings regarding vitamin D and the development of islet autoimmunity or 
T1D, further research is needed on this topic. 
 There is little research on other micronutrients associated with T1D.  It is possible 
that vitamin E could play a role in preventing the development of T1D through its 
function as an important free radical scavenger as well as through its inhibition of N-
nitroso compound formation in food and in the human organism.22  In a Finnish case-
control study within an adult cohort, an inverse relation was found between serum 
concentrations of alpha-tocopherol at baseline and the development of T1D 4-14 years 
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later; this association was independent of serum cholesterol levels and body mass index.22  
Serum selenium or retinol concentrations were not related to the risk of T1D in that same 
study.22  An Australian case-control study reported that vitamin C supplementation was 
inversely related to the risk of T1D.22  Zinc concentrations in drinking water were also 
observed to be inversely related to the risk of T1D in a Swedish case-control study.22  
Virtanen et al. (1994) found that maternal nitrite intake was positively associated with the 
risk of diabetes independent of the child’s own intake and when adjusted for several 
sociodemographic factors.23  Norwegian case-control findings of an inverse association 
between maternal cod liver oil supplementation during pregnancy and the risk of T1D in 
the offspring suggest that either vitamin D, vitamin A, or n-3 fatty acids (which are all 
abundant in cod liver oil) play a role in the development of T1D.22  Some of the 
randomized placebo-controlled trials in subjects with recently diagnosed T1D suggest 
that nicotinamide delays the decay of β cell function, whereas other studies found no 
effect of nicotinamide.22   Further research is needed on various micronutrients associated 
with the development of T1D.  
 
Obesity and Risk of Type 1 Diabetes 
 An article by Nucci et al. (2012) aimed to evaluate the relationship between early 
growth and regional variations in T1D incidence in children with familial and genetic risk 
for T1D.24  They obtained anthropometric indices between birth and 5 years of age in 
2160 children participating in the TRIGR study among different regions.24  They found 
that children in Northern Europe had the highest weight z-score between birth to 12 
months of age, while those in Southern Europe and USA had the lowest weight and 
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length for height z-scores.24  The study concluded that there are regional differences in 
early childhood growth that are consistent with the higher incidence of T1D in Northern 
Europe and Canada compared to Southern Europe.24   This study allows for further 
evaluation of the association between growth (obesity) and progression to T1D.24 
 Kibirige et al. (2003) looked at the relationship between body mass index and age 
at diagnosis of T1D.25  The relationship between fatness and age at diagnosis was 
examined in context of birth weight, weight change since birth, weight at diagnosis, BMI 
at diagnosis, and BMI 12 months later in 94 children aged 1–16 years (49 boys and 45 
girls) presenting for management of acute-onset T1D.25  The boys in this study were 
found to have a greater BMI than the girls, and they were presented with diabetes at a 
younger age.25   
 Birthweight and prevalence of overweight children have gradually increased in 
Sweden over recent decades, and this trend seems to parallel with increasing incidence of 
T1D occurring in childhood.26  Dahlquist et al. (2005) observed in a population-based 
register study that the paralleling trend between increasing birthweight/overweight and 
increasing incidence of childhood T1D is seen in the younger age-at-onset groups, but not 
in the age groups older than 15 years at diagnosis.26  One explanation could be that the 
overload of the beta cells due to increased insulin demand in the growing children may 
accelerate the process of beta-cell destruction and lead to an earlier onset on T1D.26  This 
study concluded that high birthweight as a risk factor for T1D may be limited to young-
onset cases.26  The increase in T1D incidence in Sweden is seen in age groups younger 
than 10, but not in young adults, which could be explained by the increasing 
birthweight.26 
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 Ljungkrantz et al. (2008) examined children’s height and weight gain from birth 
to the time of diagnosis of T1D.27  Growth charts from 316 children 0-16 years old up to 
the time of T1D diagnosis were compared with growth charts from age and gender 
matched controls.27  Compared with controls in the year of diagnosis, children who 
developed T1D were taller (0.5 vs. 0.36 SDS) and heavier (0.7 vs. 0.45 SDS).27  Children 
who developed diabetes at 5 years old or less gained more in weight than in height during 
the period between their third month and third year of life.27  Children who were 
diagnosed between 6 and 10 years of age gained more in height before they were 5 years 
old.27  The analysis from the study showed that a high weight or high BMI at 5 years old 
indicated, more than other measurements, a high risk (OR 1.6; 95% CI 1.02-2.38) for 
diabetes later during childhood, while height and weight at ages less than 5 years did not 
add any further information on diabetes risk.27    
 In conclusion, breastfeeding is thought to help reduce the risk of developing T1D 
in children genetically at risk.  This could be due to a number of mechanisms including 
the hormones in breast milk, the delay in introduction of complementary foods containing 
foreign antigens that affect the islet autoimmunity with longer periods of breastfeeding, 
or the protective effect that breastfeeding has against overweight/obesity in children.  
 
Breastfeeding and Obesity 
 Many studies have reported that children who are breastfed are more likely to 
maintain a healthy weight throughout childhood.  The World Health Organization 
(WHO) and United States Department of Health and Human Services have concluded 
that breastfeeding for at least six months can help reduce the risk of obesity later in life.28  
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Human milk may be involved in growth and appetite control in the neonatal period and 
infancy, affecting the programming of energy balance regulation in both childhood and 
adulthood.28   
 A review article by Marseglia et al. (2015) provides a summary of what is known 
about the possible relationship between breastfeeding and risk of obesity in childhood.28  
Findings from different studies are discussed and possible mechanisms to explain the 
association between breastfeeding and obesity are mentioned.  Human milk varies from 
day to day in composition, which influences metabolic state and diet of infant; it has been 
shown that a dose- and time-dependent association could correlate with a lower BMI in 
older children.28  This paper also states prolonged duration and exclusivity of 
breastfeeding lead to lower growth rates during the first year of life and seem to lower 
risks of overweight and obesity in preschool aged children.28  However, the data are 
controversial with regard to the effect that breastfeeding early in life has on short- and 
long-term obesity.28  The results are from observational studies, which can be affected by 
many other confounding factors such as genetics, family structure, physical activity later 
in life, and future eating patterns. 
 A 2007 meta-analysis conducted for the WHO showed that breastfeeding was 
associated with a 22% reduced risk of obesity later in life.28  In a 2013 study, researchers 
observed that exclusive breastfeeding for six to seven months of age was associated with 
decreased risk of overweight and obesity compared with formula feeding after adjusting 
for maternal factors (educational attainment, smoking status, and working status) and 
child factors (gender, television viewing time, and computer game playing time).28  
However, a cohort study of 8327 children from Hong Kong China did not find any 
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association between breastfeeding and BMI at seven years of age.28  Not all authors agree 
on the relationship between breastfeeding and overweight, so there is still the need for 
further studies to clarify the association between the two.   
 The duration of breastfeeding can directly influence the infant’s ability to self-
regulate milk intake and the infant’s growth.  As a result, there are differences between 
growth parameters in infants who are breastfed for a short vs. long time period.28  A 
meta-analysis about the duration of breastfeeding and obesity, using formula fed infants 
as the referent, noted that duration of breastfeeding and overweight were inversely 
correlated.28  A shorter duration of breastfeeding is probably associated with an earlier 
introduction of solid food, which contains more protein than breast milk.28  Shorter 
duration of breastfeeding was correlated with reduced appetite signaling which induces a 
greater number of feeding times.  Recent studies have identified the role of the fat mass- 
and obesity-associated (FTO) gene in increasing BMI and adiposity.  Abarin et al. (2012) 
hypothesized that the longer duration of breastfeeding, through its ability to interfere on 
the FTO gene, might reduce the risk of overweight later in life.28  In 18 studies, duration 
of breastfeeding, if greater than 40 weeks, was positively related with a lower weight gain 
at one year.28  
 Several hormone molecules seem to be involved in the development of obesity in 
humans.  Insulin, insulin-like growth factor I (IGF-1), leptin, adiponectin, ghrelin, 
obestatin, and resistin are hormone molecules involved in the development of obesity.28  
These hormones influence fat and lean body mass in healthy term infants and enhance 
appetite signaling, which promotes child satiety-responsiveness and decreases risk of 
over-eating.28  Leptin promotes fetus growth, has a positive effect on satiety, increases 
15 
 
basal metabolism, and correlates with weight gain in newborns.28  Leptin is synthesized 
and secreted in breast milk; it has been reported that higher serum leptin levels are found 
during the first month of life in breast-fed infants than in formula fed infants.28  
Adiponectin is released in breast milk.  Adiponectin levels in newborns are directly 
associated with birth weight and length, insulin sensitivity, and levels of leptin, and 
inversely related with fat deposits and weight gain.28  Ghrelin is present in human milk 
during lactation.28  Ghrelin is directly associated with birth weight, birth length, and age; 
ghrelin is inversely related with weight gain in breastfed newborns of at least four 
months, but not in formula fed infants.28  Obestatin is a hormone derived from the same 
gene that codes for ghrelin.  Obestatin is synthesized by ductal epithelium of mammary 
gland or directly released from serum into breast milk and has been detected in colostrum 
and mature milk.28  Obestatin is associated with less overfeeding, especially in the early 
stages of breastfeeding.28  Although further studies are needed to clarify other factors 
associated with breastfeeding and weight gain, these findings do suggest that breast milk 
can play a critical role in metabolic development of newborns. 
 A study by Hunsberger (2014) aimed to show the association between 
breastfeeding and overweight children when considering family structure.29  The 
researchers suggested that breastfeeding alone does not protect children from being 
overweight, but that other lifestyle and social factors play a role along with mothers who 
chose to breastfeed.  The WHO recommends children be exclusively breastfed for at least 
six months because of other known benefits.  The group that published this paper 
reviewed the exposure to exclusive breastfeeding and overweight in the “Identification 
and prevention of Dietary- and lifestyle-induced health EFfects In Children and infantS 
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(IDEFICS)” study.29  IDEFICS was a multi-center European study that involved eight 
different countries.29  Only children who could be defined as being exclusively breastfed 
were included in the surveys for this study.29  Exclusive breastfeeding and 
overweight/obesity combined were examined with adjustment for survey country, child 
age, sex and birth weight, household income, maternal education, maternal 
overweight/obesity, single or dual parent family structure, presence of one or more 
foreign born parents, and tobacco use during pregnancy.29  In the fully adjusted model, 
breastfeeding exclusively for four to six months was protective for overweight/obesity 
when compared to children who were never exclusively breastfed.29  Also, exclusive 
breastfeeding for six months showed more protection than four and five months 
combined.29  When the role of family structure was investigated, being an only child was 
not protective for children becoming overweight/obese.29  Although exclusive 
breastfeeding for four to six months can be protective for overweight/obesity, it is 
important to keep in mind that exclusive breastfeeding alone will not guarantee that 
children will not become overweight or obese due to other environmental factors such as 
family structure.29 
 A review by Spatz (2014) discussed the mechanism for how breastfeeding can 
influence future eating habits.30  Infants learn about food and flavoring through both 
amniotic fluid and breastfeeding.30  Human milk is influenced by maternal diet; when an 
infant breastfeeds, the palate is exposed to new tastes.30  These early exposures to various 
tastes have an influence on flavor preferences of children that may later affect food 
choices.30  Research conducted on Dutch children found that children at seven years of 
age who were breastfed for more than 16 weeks had a greater intake of fruits and 
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vegetables compared to those children who had never been breastfed.30  The children who 
had been breastfed were also less likely to consume white bread, soft drinks, chocolate 
bars, and fried food.30  These findings provide evidence that breastfeeding can be 
protective against children being overweight/obese due to the effects breastfeeding can 
have on future food choices in children.  
  
Methodology 
Study Population    
 The TRIGR study is an international T1D prevention trial designed to determine 
whether weaning to a hydrolyzed infant formula reduces the incidence of T1D in children 
with a first- degree relative with the disease and increased HLA-defined genetic risk.5  
Mothers with T1D diabetes were identified during pregnancy through endocrinologists or 
high-risk pregnancy services.5  Fathers with T1D were identified by available history or 
data already in the medical record of the pregnant women, interviewing women at 
prenatal maternity clinic visits, and existing registries of T1D in some centers.5  The 
newborn infants with a first-degree relative with T1D also had to fit the inclusion and 
exclusion criteria to be recruited.  The inclusion criteria included: the biological parent 
and/or full (not half) sibling of the newborn infant had T1D as defined by the WHO; the 
infant’s parents or legal guardians gave signed consent to participate; and the infant had 
one of four different genotypes listed in the study [HLA-DQB1*02/0302; 
HLA-DQB1*0302/x (x DQB1*02, *0301, *0602); HLA-DQA1*05 -DQB1*02/y (y 
DQA1*0201 -DQB1*02, DQB1*0302, *0301, *0602, *0603); HLA-DQA1*03 -
DQB1*02/y (y DQA1*0201 -DQB1*02, DQB1*0302, *0301, *0602, *0603)].5  The 
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newborn infants could not be recruited if they met any of the exclusion criteria.  
Exclusion criteria for the study included: having an older sibling who had already been 
included in the TRIGR intervention; multiple gestation; parents were unwilling or unable 
to feed the infant cow milk (CM)-based products for any reason; the newborn infant had 
a recognizable severe illness; the gestational age of the newborn infant was less than 35 
weeks; inability of the family to take part in the study (the family had no access to any of 
the study centers or the family had no telephone); the infant had received any infant 
formula other than Nutramigen prior to randomization; the infant was older than 7 days at 
randomization; and no HLA sample had been drawn before the age of 8 days.5 
 Recruitment for the study was carried out over the course of 4 years in 6 major 
centers in the USA, in 18 centers in Canada, in 51 centers in 12 European countries, and 
3 centers in New South Wales, Australia.  In order to facilitate recruitment and minimize 
any possible unintentional exposure to CM protein, attempts to identify and randomize 
eligible families were made before the child was born.5 
 Using data from the Childhood Diabetes in Finland (DiMe) Study Group, the 
German BABYDIAB study, and the DAISY study, a projected sample size of 2032 
infants to be randomized for the trial was determined.5  To achieve this number, the 
TRIGR study group determined that 4516 infants had to be screened assuming a 
frequency of 45% of the genotypes conferring increased risk.5  Screening for TRIGR 
began on 1 May 2002 and the target enrollment was achieved by 1 September 2006.5  A 
paper published on the recruitment and retention of the TRIGR study by Franciscus et al. 
(2013) stated that 5606 mothers registered worldwide, and 5000 of their infants were 
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randomized.31  Of these, 2159 were HLA eligible and enrolled in the 8-month 
intervention and 10-year follow up phases of the study.31 
  
Anthropometrics  
 The weight and length or height of subjects were recorded at the time of 
randomization (baseline).  Anthropometrics were subsequently measured at the 3 month 
visit, 6 month visit, 9 month visit, 12 month visit, 18 month visit, 2 year visit, and at each 
annual visit thereafter until the maximum age of 14 years.5 
  
Nutrition Assessment  
 In the TRIGR Study, the diet of the child and the compliance with avoiding intact 
CM proteins were assessed by interview at the delivery hospital.5  The interview was 
conducted via telephone with parents/guardians when the infant was 2 weeks of age and 
1, 2, 4 and 5 months old.5  The interview was also conducted in person at the 3- and 6-
month visits.5  If the infant continued in the intervention after 6 months of age, telephone 
interviews were also done at 7 and 8 months old.5  The dietary assessment was done via a 
structured form, including information on the duration of total and exclusive 
breastfeeding, the age at introduction, the duration of the study formula feeding, and the 
amount of study formula given per feeding.5  The families were also asked about intake 
of allowed foods and non-recommended foods and food groups.5  Measuring CM protein 
antibody levels from sera at 3 months and 6 months also assessed compliance with the 
avoidance of intact CM proteins.5 
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 The dietary interview form given at the two-week follow-up call included two 
questions about what the baby had consumed at all during the first 3 days, and also what 
the baby consumed primarily in the first 3 days (Appendix A).  Then, a few questions 
were asked about breastmilk consumption and study formula consumption; the subjects 
were asked if they needed more study formula and how much of the study formula they 
had at home at the time of 2 weeks.  At 2 weeks, the families were asked about which 
types of foods and supplements were consumed and how frequently the baby had 
consumed these items since birth.  The foods included: breast milk, study formula, 
strained potato/vegetables, strained fruit/fruit juices, foods containing oat, wheat, barley, 
or rye, foods containing corn, rice, buckwheat, or millet, foods containing pork, chicken, 
turkey, lamb, or game, and foods containing fish or egg or any other foods not previously 
mentioned.  The supplements included vitamin D or cod liver oil, and other 
vitamins/minerals.   
 At months one through five, the dietary form included questions about a few 
additional foods not asked about at the two-week follow-up (Appendix B).  These forms 
included questions about consumption of regular cow’s milk/goat’s milk based formula, 
Nutramigen or other hydrolyzed formula, soy-based formula, soured milk and sour milk 
products (buttermilk, cultured milk, yogurt), regular cow’s milk/goat’s milk, ice cream or 
cheese, foods containing beef, veal, or meat extract, sausage and other meat products 
containing beef, and any others not listed above that may contain lactic acid bacteria.  An 
additional form was filled out at the six-month follow-up visit.  This form included 
questions about the same foods asked about in the previous forms.  Parents were also 
asked if the baby had already received the study formula and if the baby had received the 
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study formula daily for at least 2 months.  Parents were asked to indicate how much study 
formula they still had at their home at the time of the 6-month visit, and how much 
unconsumed study formula the family returned after the intervention period. 
  
Statistical Analysis  
 Frequency analysis will be used to describe the demographic and anthropometric 
characteristics of the total study population and stratified by maternal T1D status.  
Frequency analysis will also be conducted using the variables: region, maternal 
education, gender, HLA-genotype, method of delivery, birth weight and birth length, 
ponderal index (birth only), body mass index (BMI), length of exclusive breastfeeding 
(EBF), and maternal T1D status (MT1D).  Normality statistics will be performed for the 
continuous variables.  Mean and median values will be calculated for weight/age, length 
or height/age, and BMI/age (at birth and each subsequent time period) for the entire 
cohort and by MT1D status.  Ponderal Index will be used at birth rather than BMI.  
Overweight and obesity status will be determined for each participant using International 
Obesity Task Force (IOTF) BMI cutoff points for overweight and obesity by age and 
gender.  The rates (percentages) of overweight and obesity at birth and each subsequent 
time period will also be calculated.   
 In order to evaluate the association between length of exclusive breastfeeding and 
obesity by 10 years of age, a model will be created to assess the association between 
length of exclusive breastfeeding and obesity rate after adjusting for covariates.  Another 
model will be created to evaluate the association between length of exclusive 
breastfeeding and growth rate.  This model will assess the association between length of 
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exclusive breastfeeding and growth curves for weight, height/length, and BMI after 
adjusting for covariates (gender, method of delivery, HLA-genotype, birth weight, birth 
height/length, and MT1D).  Weight/height data with suspected errors are corrected using 
statistical algorithm prior to analysis.  Race was removed from the analysis because it 
was only documented in the U.S.  Analysis will be divided by the following regions: 
Australia, Canada, Northern Europe, Southern Europe, Central Europe I, Central Europe 
II, and the United States.  Type III SS model is the best because it controls for other 
variables.  P-values will be viewed for significance.   
 
Summary/Conclusion 
 The effect of exclusive breastfeeding on the development of overweight/obesity in 
children at risk for T1D is unknown.  The purpose of this project was to review the 
literature for research that has evaluated the association between infant diet, including 
breastfeeding and complementary foods, and the development of obesity in children at 
risk for T1D.  After completion of the literature review, a secondary analysis proposal 
was developed to investigate this relationship in a large population of children who 
participated in a large international T1D prevention trial.  Previous research has reported 
that exclusive breastfeeding for greater than two weeks can be protective against 
developing T1D, whereas early exposure to cow’s milk-based protein may increase beta-
cell autoimmunity.14  In addition, mothers with T1D breastfeed less frequently than those 
unaffected by the disease.16  The timing of introduction to complementary foods seems to 
affect islet autoimmunity.17   Studies have shown an association between weight status in 
children and development of T1D25,27 while breastfeeding has been found to be protective 
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against overweight/obesity in children.28  The proposal has been prepared to examine the 
association between length of exclusive breastfeeding and obesity risk in children at risk 
for T1D for submission to the Presentations and Publications Committee of the Trial to 
Reduce IDDM in the Genetically at Risk (TRIGR) study.  The TRIGR study data are 
ideally suited to answer this research question because there are controls for many 
important confounding factors pertaining to this research question. Furthermore, the 
study was conducted in an international population from birth to up to 14 years of age.  A 
prospective study from birth will allow evaluation of relationships between exclusive 
breastfeeding and the development of overweight/obesity in children at risk for T1D 
during infancy, childhood and early adolescence.  
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Nutritional Prevention of Type 1 Diabetes North America Region 
Contact no. 2 
Two Week Follow-up Call 
 
DIETARY INTERVIEW 2 weeks 
 
Study Center I   I   I   I   I   I   Local Code I   I__I   I   I   I__I   I   I   I 
Registration Code I  I  I  I  I  I  I Randomization Code I  I  I  I 
 
 
Date I  I  I  I_    I_    I_    I    _I    _I    _I Form completed by    
d d m   m m y y y y Print name 
 
Code I   I   I   I   I 
 
DIET OF THE BABY DURING THE FIRST 3 DAYS (in the hospital or at home) 
           
e. Has your baby received the following types of milk during the first 3 days?  Mark (X) a response for 
each type of milk. Also, very tiny amounts should be recorded in the column “yes.” 
 
 
Yes 
 
No 
Don’t 
know 
Own mother’s breast milk    
Banked breast milk    
Study Formula    
Nutramigen    
Nutramigen LIPIL    
Other infant formula 
Brand name(s)?    
National code(s) I    I    I__I ,  I    I    I    I 
   
Other type of milk 
Brand name(s)?    
National code(s) I    I    I__I ,  I    I    I    I 
   
 
2.   What type of milk did your baby primarily receive during the first 3 days?  Circle the one most 
frequently used type of milk. If the baby has received two of them equally as often (e.g., its own mother’s breast 
milk and the Study Formula), both numbers should be circled. 
1. Own mother’s breast milk 
2. Banked breast milk 
3. Study Formula 
4. Nutramigen 
5. Nutramigen LIPIL 
6.   Other infant formula, brand name?    
National code for the formula: I    I    I    I , I    I    I    I 
7.   Other type of milk, please give details   
National code for the type of milk:  I    I    I    I , I    I    I    I 
8. I don’t know what type of milk my baby received primarily 
9. None 
TRIGR Form 304 
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Nutritional Prevention of Type 1 Diabetes North America Region 
 
Contact no. 2 
Two Week Follow-up Call 
DIETARY INTERVIEW 2 weeks 
 
 
Study Center I  I  I  I  I  I   Local Code I  I   _I  I  I  I  I  I  I  I  Registration Code I  I  I  I  I  I  I 
 
 
 
DIET OF THE BABY DURING THE FIRST 2 WEEKS 
 
3. Is your baby now receiving breast milk?  Please give the mother the following options, and circle the one 
that is found most appropriate by her: 
1. Yes 
 
2. No, breast feeding was stopped at the age of    days 
 
3.   No, my baby has not been breast fed at all 
 
4. Has your baby started to receive anything other than breast milk or water (e.g., Study Formula, 
Nutramigen, juice, sugar water, strained potato/vegetables, baby cereals)? 
1. Yes 
2.   No 
 
¾ If yes:  When did your baby receive it for the first time?  At the age of    days 
 
5.   Has your baby already received the Study Formula? 
1. Yes 
2.   No 
¾ If yes:   When did your baby receive the Study Formula for the first time?  At the age of    days 
How long has the baby received the Study Formula daily so far?     Days 
How much Study Formula has your baby received on average per feeding during the first 
two weeks? 
   Scoops Study Formula powder or    ml (milliliters) Study Formula liquid 
 
¾ If no:  Skip question 6 and go to question 7 
 
6.   Is your baby now receiving the Study Formula? 
1. Yes 
2.   No 
 
¾ If no:  When did your baby receive the Study Formula last time?  At the age of    days 
 
7.   How much unconsumed Study Formula do you have at home at the time of the 2-week call? 
Whole cases of formula    case(s) 
Individual cans of formula    can(s) 
 
8.   Do you need more Study Formula? 
1. Yes 
2.   No 
 
¾ If yes:  Please complete  the Study Formula Distribution Form (Form 302) 
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TRIGR Form 304 
Nutritional Prevention of Type 1 Diabetes North America Region 
 
Contact no. 2 
Two Week Follow-up Call 
DIETARY INTERVIEW 2 weeks 
 
Study Center I  I  I  I  I  I   Local Code I  I   _I  I  I  I  I  I  I  I  Registration Code I  I  I  I  I  I  I 
 
 
9.   Which foods has your baby received since birth, and how often? 
 
The purpose of this question is to assess how often your baby has consumed the foods listed below since 
birth. Mark (X) each row of the table appropriately to indicate how often the baby has received the food(s). 
If the baby has not consumed any food items in the row, mark the column “not at all”.  If the food was 
consumed more than 6 times per week, mark the appropriate “Times per day” box.  Please do not use the 
last category “Other food item” unless it is absolutely necessary. Instead, try to use the specific food 
categories as much as possible for the foods consumed by the baby. There must be only one mark in 
each row. 
Type of food Average frequency since birth 
 
 
 
Not at all 
Times per week Times per day 
Less 
than 1 
1-3 4-6 1-2 3-4 5 or more 
 
Breast milk 
       
 
Study Formula 
       
 
Strained potato / vegetables 
       
 
Strained fruit / fruit juices 
       
Foods containing oat, wheat, barley 
or rye (e.g., baby cereals, bread, 
biscuits) 
       
Foods containing corn, rice, 
buckwheat or millet (e.g., baby 
cereals, bread, biscuits) 
       
 
Foods containing pork, chicken, 
turkey, lamb, or game (e.g., strained 
meat and vegetables) 
       
Foods containing fish 
(e.g., strained fish and vegetables) 
       
 
Egg        
Vitamin D supplementation or cod 
liver oil – please list: 
       
Other vitamins/minerals, please list:        
Other food item – please list:        
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TRIGR Form 304 
Nutritional Prevention of Type 1 Diabetes North America Region 
 
Contact no. 2 
Two Week Follow-up Call 
DIETARY INTERVIEW 2 weeks 
 
Study Center I  I  I  I  I  I   Local Code I  I   _I  I  I  I  I  I  I  I  Registration Code I  I  I  I  I  I  I 
 
10. Has your baby received any foods that are not allowed during the dietary intervention period? 
 
Foods not allowed during the dietary intervention period are mentioned in the table below. In case the baby 
has received any of those since birth, mark (X) each row of the table appropriately to indicate how often 
the baby has received the food(s). If the baby has not consumed any food items in the row, mark the 
column “not at all”. If the food was consumed more than 6 times per week, mark the appropriate “Times per 
day” box. There must be only one mark in each row. 
Type of food Average frequency since birth 
 
 
Not at all 
Times per week Times per day 
Less than 
1 
1-3 4-6 1-2 3-4 5 or more 
Regular cow’s / goat’s 
milk-based formula, as 
such or used in cooking 
Brand name(s)?   National code(s) I   I   I   I , I__I    I   I 
       
Nutramigen* or other 
hydrolyzed formula** 
Brand name(s)?   National code(s) I   I   I   I  
       
Soy-based formula** 
Brand name(s)?   National code(s) I   I   I   I  
       
 
Soured milk and sour milk 
products 
(e.g., buttermilk, cultured milk, 
yogurt) 
       
Regular cow’s / goat’s milk, ice 
cream 
or cheese, as such, in 
commercial baby foods, or 
when used in cooking (e.g., 
baby foods) 
       
Foods containing beef, 
veal or meat extract (e.g., 
strained beef and 
vegetables) 
       
 
Sausage and other meat 
products containing beef 
       
Other – please list (e.g., milk 
containing lactic acid bacteria 
supplements) 
       
*  Nutramigen can be given in the delivery hospital if the Study Formula is not available 
** Other infant formulas than the Study Formula are not allowed during the dietary intervention period 
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TRIGR Form 305 
Nutritional Prevention of Type 1 Diabetes North America Region 
Contact no. 3 
One-Month Follow-up Call 
 
DIETARY INTERVIEW 1 month 
 
Study Center I   I   I   I   I   I   Local Code I   I__I   I   I   I__I   I   I   I 
Registration Code I  I  I  I  I  I  I Randomization Code I  I  I  I 
 
 
Date I  I  I  I_    I_    I_    I    _I    _I    _I Form completed by    
d d m m m   y y y y Print name 
Code I   I   I   I   I 
 
1. Is your baby now receiving breast milk?  Please give the mother the following options, and circle the one 
that is found most appropriate by her: 
1. Yes 
 
2. No, breast feeding was stopped at the age of    days 
 
3.   No, my baby has not been breast fed at all 
 
2. Has your baby started to receive anything other than breast milk or water (e.g., Study Formula, 
Nutramigen, juice, strained potato/vegetables, baby cereals)? 
1. Yes 
2.   No 
¾ If yes:  When did your baby receive it for the first time?  At the age of    days 
 
3.   Has your baby already received the Study Formula? 
1. Yes 
2.   No 
¾ If yes:   When did your baby receive the Study Formula for the first time?  At the age of    days 
How long has the baby received the Study Formula daily so far?     days 
How much Study Formula has your baby received on average per feeding during  the 
preceding two weeks? 
   scoops Study Formula powder or    ml (milliliters) Study Formula liquid 
 
¾ If no:  Skip question 4 and go to question 5 
 
4.   Is your baby now receiving the Study Formula? 
1. Yes 
2.   No 
¾ If no:  When did your baby receive the Study Formula last time?  At the age of    days 
 
5.   How much unconsumed Study Formula do you have at home at the time of the 1-month call? 
Whole cases of formula    case(s) 
Individual cans of formula    can(s) 
 
6.   Do you need more Study Formula? 
1. Yes 
2.   No 
¾ If yes:  Please complete  the Study Formula Distribution Form (Form 302) 
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TRIGR Form 305 
Nutritional Prevention of Type 1 Diabetes North America Region 
 
Contact no. 3 
One-Month Follow-up Call 
DIETARY INTERVIEW 1 month 
 
Study Center I  I  I  I  I  I   Local Code I  I   _I  I  I  I  I  I  I  I  Registration Code I  I  I  I  I  I  I 
 
 
7.   Which foods has your baby received since the 2-week call, and how often? 
 
The purpose of this question is to assess how often your baby has consumed the foods listed below since 
the 2-week call.  Mark (X) each row of the table appropriately to indicate how often the baby has received 
the food(s). If the baby has not consumed any food items in the row, mark the column “not at all”.  If the 
food was consumed more than 6 times per week, mark the appropriate “Times per day” box.  Please do not 
use the last category, “other food item”, unless it is absolutely necessary. Instead, try to use the specific 
food categories as much as possible to describe the foods consumed by the baby. There must be only 
one mark in each row. 
Type of food Average frequency since the 2-week call 
 
 
 
Not at all 
Times per week Times per day 
Less 
than 1 
1-3 4-6 1-2 3-4 5 or more 
 
Breast milk 
       
 
Study Formula 
       
 
Strained potato / vegetables 
       
 
Strained fruit / fruit juices 
       
Foods containing oat, wheat, barley 
or rye (e.g., baby cereals, bread, 
biscuits) 
       
Foods containing corn, rice, 
buckwheat or millet (e.g., baby 
cereals, bread, biscuits) 
       
 
Foods containing pork, chicken, 
turkey, lamb, or game (e.g., strained 
meat and vegetables) 
       
Foods containing fish 
(e.g., strained fish and vegetables) 
       
 
Egg        
Vitamin D supplementation or cod 
liver oil – please list: 
       
Other vitamins/minerals, please list:        
Other food item – please list:        
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TRIGR Form 305 
Nutritional Prevention of Type 1 Diabetes North America Region 
Contact no. 3 
One-Month Follow-up Call 
DIETARY INTERVIEW 1 month 
 
Study Center I  I  I  I  I  I   Local Code I  I   _I  I  I  I  I  I  I  I  Registration Code I  I  I  I  I  I  I 
 
8. Has your baby received any foods since the 2-week call that are not allowed during the dietary 
intervention period? 
Foods not allowed during the dietary intervention period are mentioned in the table below. In case the baby 
has received any of those since the 2-week call, mark (X) each row of the table appropriately to indicate 
how often the baby has received the food(s). If the baby has not consumed any food items in the row, mark 
the column “not at all”.  If the food was consumed more than 6 times per week, mark the appropriate “Times 
per day” box.  There must be only one mark in each row. 
Type of food Average frequency since the 2-week call 
 
 
Not at all 
Times per week Times per day 
Less 
than 1 
1-3 4-6 1-2 3-4 5 or more 
Regular cow’s / goat’s 
milk-based formula, as 
such or used in cooking 
Brand name(s)?   National code(s) I   I   I   I 
       
Nutramigen or other 
hydrolyzed formula* 
Brand name(s)?   National code(s) I   I   I   I  
       
Soy-based formula* 
Brand name(s)?   National code(s) I   I   I   I  
       
 
Soured milk and sour milk 
products (e.g., buttermilk, 
cultured milk, yogurt) 
       
Regular cow’s / goat’s milk, 
ice cream or cheese, as 
such, in commercial baby 
foods, or when used in 
cooking (e.g., baby foods) 
       
Foods containing beef, 
veal or meat extract (e.g., 
strained beef and 
vegetables) 
       
Sausage and other meat 
products containing beef 
       
Other – please list 
(e.g., milk containing 
lactic acid bacteria 
supplements) 
       
* Other infant formulas than the Study Formula are not allowed during the dietary intervention period 
 
